Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: J Immunol. 2013 May 1;190(11):5818–5828. doi: 10.4049/jimmunol.1203452

Figure 8.

Figure 8

Alloreactive Notch-deprived CD8+ T cells maintain high cytotoxic potential. (A) In vivo cytotoxicity assay. Transplanted BALB/c recipient mice were challenged on day 14 with a 1:1 mixture of CFSE-labeled allogeneic targets and control cells (CFSEHigh H-2Kd+ BALB/c and CFSElow control H-2Kb+ B6-CD45.1 splenocytes, respectively). After 18 hours, elimination of the BALB/c targets was assessed in the spleen by flow cytometry; (B) BALB/c recipients were transplanted with TCD BM and WT or DNMAML splenocytes (5×106 each). On day 8, alloreactive WT and DNMAML and naïve CD8+ T cells were MACS-purified and incubated with 51Chromium-labeled tumor cells at various E:T ratios for 5 hours (representative of n=3 independent experiments). A20 and P815 cells were allogeneic targets (H2kd). EL4 cells were syngeneic controls (H2kb). **p<0.01; ***p<0.001.